These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3793205)

  • 1. Response of human neutrophils to formyl-peptide modified at the terminal amino and carboxyl groups.
    Spisani S; Cavalletti T; Gavioli R; Scatturin A; Vertuani G; Traniello S
    Inflammation; 1986 Dec; 10(4):363-9. PubMed ID: 3793205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
    Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
    Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New chemotactic peptide analogs with high biological activity for human neutrophils.
    Spisani S; Traniello S; Giuliani AL; Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Pochetti G; Lucente G
    Biochem Int; 1992 May; 26(6):1125-35. PubMed ID: 1321622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analog of formyl-met-leu-phe effects the movement of human leukocytes].
    Cavalletti T; Spisani S; Gavioli R; Marangoni C; Scatturin A; Vertuani G; Traniello S
    Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1103-9. PubMed ID: 6548144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
    Bonora GM; Toniolo C; Freer RJ; Becker EL
    Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
    J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine.
    Patrone F; Dallegri F; Sacchetti C
    Res Exp Med (Berl); 1980; 177(1):19-22. PubMed ID: 7403684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them.
    Koike M; Nagashima K; Saito K; Nakanishi M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1991 Feb; 175(1):165-72. PubMed ID: 1847803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the structural requirements for synthetic formyl peptide chemoattractants.
    Kraus JL
    Pharmacol Res Commun; 1986 Jul; 18(7):611-6. PubMed ID: 3763672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
    Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
    J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear gramicidin activates neutrophil functions and the activation is blocked by chemotactic peptide receptor antagonist.
    Jacob J
    FEBS Lett; 1988 Apr; 231(1):139-42. PubMed ID: 2452097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives.
    Zecchini GP; Paradisi MP; Torrini I; Spisani S
    Arch Pharm (Weinheim); 1995 Sep; 328(9):673-6. PubMed ID: 7487425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal oxidative activity and chemotaxis of circulating neutrophils in patients treated with photopheresis.
    Obel N; Storgaard M; Hansen B; Zachariae H
    Arch Dermatol Res; 1994; 286(1):18-20. PubMed ID: 8141608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.
    Marasco WA; Phan SH; Krutzsch H; Showell HJ; Feltner DE; Nairn R; Becker EL; Ward PA
    J Biol Chem; 1984 May; 259(9):5430-9. PubMed ID: 6371005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha decreases neutrophil chemotaxis to N-formyl-1-methionyl-1-leucyl-1-phenylalanine: analysis of single cell movement.
    Vollmer KL; Alberts JS; Carper HT; Mandell GL
    J Leukoc Biol; 1992 Dec; 52(6):630-6. PubMed ID: 1464735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some remarkable effects of thiopeptide and derived linkages on lysozyme release from neutrophils by esters of the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe-OR).
    Belleau B; Lajoie G; Sauve G; Rao VS; di Paola A
    Int J Immunopharmacol; 1989; 11(5):467-71. PubMed ID: 2807625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G; Fraulini A; Falzarano S; Spisani S
    Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and chemotactic activity of the fMLP analog HCO-Hmb-Leu-Phe-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Lucente G; Traniello S; Spisani S
    Arch Pharm (Weinheim); 1993 Aug; 326(8):461-5. PubMed ID: 8215843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF; Mehta J; Spilberg I
    Biochem Pharmacol; 1984 Feb; 33(3):407-12. PubMed ID: 6142713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.